These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 1696775

  • 1. Studies on the polyoma virus tumor-specific transplantation antigen (TSTA).
    Dalianis T.
    Adv Cancer Res; 1990; 55():57-85. PubMed ID: 1696775
    [No Abstract] [Full Text] [Related]

  • 2. Vaccination against polyoma virus (PyV) tumors using vaccinia-PyV recombinants: a major tumor-specific transplantation antigen (TSTA) epitope resides within the C-terminal segment of middle-T protein.
    Kieny MP, Gautier C, Tomasetto C, Kuhn I, Hareuveni M, Clertant P, Lathe R.
    Int J Cancer; 1990 Jan 15; 45(1):185-9. PubMed ID: 1688831
    [Abstract] [Full Text] [Related]

  • 3. A polyomavirus tumor-specific transplantation antigen (TSTA) epitope is situated within the N-terminal amino acid sequence common to middle and small T-antigens.
    Reinholdsson G, Ramqvist T, Brandberg J, Dalianis T.
    Virology; 1988 Oct 15; 166(2):616-9. PubMed ID: 2459846
    [Abstract] [Full Text] [Related]

  • 4. The mutagenic and immortalizing potential of polyoma virus large T antigen.
    Strauss M, Lübbe L, Kiessling U, Platzer M, Griffin BE.
    Curr Top Microbiol Immunol; 1989 Oct 15; 144():129-134. PubMed ID: 2551578
    [No Abstract] [Full Text] [Related]

  • 5. Immunization against the polyoma tumor-specific transplantation antigen (TSTA) with polyoma T-antigens.
    Ramqvist T, Pallas DO, DeAnda J, Ahrlund-Richter L, Reinholdsson G, Roberts TM, Schaffhausen BS, Dalianis T.
    Int J Cancer; 1988 Jul 15; 42(1):123-8. PubMed ID: 2839427
    [Abstract] [Full Text] [Related]

  • 6. A single peptide derived from the sequence common to polyoma small and middle T-antigen induces immunity against polyoma tumors.
    Ramqvist T, Reinholdsson G, Carlquist M, Bergman T, Dalianis T.
    Virology; 1989 Sep 15; 172(1):359-62. PubMed ID: 2475972
    [Abstract] [Full Text] [Related]

  • 7. Immunopathology of polyoma-induced tumors.
    Vandeputte M.
    Springer Semin Immunopathol; 1982 Sep 15; 4(4):317-32. PubMed ID: 6293109
    [No Abstract] [Full Text] [Related]

  • 8. Immunization against polyoma tumors with synthetic peptides derived from the sequences of middle- and large-T antigens.
    Reinholdsson-Ljunggren G, Ramqvist T, Ahrlund-Richter L, Dalianis T.
    Int J Cancer; 1992 Jan 02; 50(1):142-6. PubMed ID: 1370225
    [Abstract] [Full Text] [Related]

  • 9. Studies on polyomavirus persistence and polyomavirus-induced tumor development in relation to the immune system.
    Berke Z, Dalianis T.
    Adv Cancer Res; 2000 Jan 02; 79():249-76. PubMed ID: 10818683
    [No Abstract] [Full Text] [Related]

  • 10. Antiviral CD8+ T cell responses in neonatal mice: susceptibility to polyoma virus-induced tumors is associated with lack of cytotoxic function by viral antigen-specific T cells.
    Moser JM, Altman JD, Lukacher AE.
    J Exp Med; 2001 Mar 05; 193(5):595-606. PubMed ID: 11238590
    [Abstract] [Full Text] [Related]

  • 11. PAb1614, a monoclonal antibody reactive with the tumor antigens of SV40, JC, BK, and polyoma virus, and other JC virus tumor antigen cross-reactive antibodies of the PAb1601-1636 panel.
    Hess R, Oberbeck J, Grussenmeyer T, Schoeffel-Keller A, Haessler C, Braun DG, Brandner G.
    Intervirology; 1994 Mar 05; 37(1):47-52. PubMed ID: 7523331
    [Abstract] [Full Text] [Related]

  • 12. Polyoma T-antigen-derived synthetic peptides induce polyoma-virus-specific macrophage migration inhibition.
    Reinholdsson G, Ramqvist T, Szigeti R, Dalianis T.
    Int J Cancer; 1989 Jun 15; 43(6):1165-8. PubMed ID: 2543648
    [Abstract] [Full Text] [Related]

  • 13. A short peptide eluted from the H-2Kb molecule of a polyomavirus-positive tumor corresponds to polyomavirus large T antigen peptide at amino acids 578 to 585 and induces polyomavirus-specific immunity.
    Berke Z, Palmer S, Bergman T, Wester D, Svedmyr J, Linder S, Jornvall H, Dalianis T.
    J Virol; 1996 May 15; 70(5):3093-7. PubMed ID: 8627788
    [Abstract] [Full Text] [Related]

  • 14. Membrane antigens associated with infection, transformation, and tumorigenesis by polyoma virus.
    Witz IP, Meyer G.
    Cancer Immunol Immunother; 1984 May 15; 17(3):147-53. PubMed ID: 6090013
    [Abstract] [Full Text] [Related]

  • 15. Detection of a polyoma virus-induced tumor-associated membrane antigen in mouse cells by the macrophage migration inhibition test.
    Ramqvist T, Dalianis T, Reinholdsson G, Klein G, Szigeti R.
    Cancer Res; 1986 Oct 15; 46(10):5045-8. PubMed ID: 3019520
    [Abstract] [Full Text] [Related]

  • 16. Delayed hypersensitivity to polyoma and "self" antigens in syngeneic mice.
    Ochałek T, Burzyński A, Cadel Z, Chłap Z, Porwit-Bóbr Z.
    Neoplasma; 1987 Oct 15; 34(4):441-51. PubMed ID: 2821418
    [Abstract] [Full Text] [Related]

  • 17. Polyoma T antigens.
    Eckhart W.
    Adv Cancer Res; 1981 Oct 15; 35():1-25. PubMed ID: 6280456
    [No Abstract] [Full Text] [Related]

  • 18. Polyoma virus-induced tumor-specific transplantation antigen (TSTA) is a mouse and rat cross-species-reacting antigen.
    Ramqvist T, Dalianis T.
    Eur J Cancer Clin Oncol; 1984 Dec 15; 20(12):1557-60. PubMed ID: 6094200
    [No Abstract] [Full Text] [Related]

  • 19. Studies on the polyoma-virus-induced tumor-specific transplantation antigen (TSTA)--does middle or large T-antigen play a role?
    Dalianis T, Ramqvist T, Klein G.
    Int J Cancer; 1984 Sep 15; 34(3):403-6. PubMed ID: 6090322
    [Abstract] [Full Text] [Related]

  • 20. Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein.
    Lukacher AE, Wilson CS.
    J Immunol; 1998 Feb 15; 160(4):1724-34. PubMed ID: 9469430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.